A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)
NCT05652712
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
Toripalimab
Sponsor
Qianfoshan Hospital